Friday, September 3, 2010
"The source for European pharmaceutical biotechnology news..."
Looming patent cliffs and shrivelling pipelines have pharma's big players looking for new business models that will allow them to increase their bottom lines.
1 of 10
Previous |
Next
Executive Interviews
Enabling greater clinical trial efficiency
Paula Mchale delves into the world of clinical trials and offers her expertise on how technology could enable better efficiency.
No Comments
Barriers to successful biopharmaceutical commercialisation
Mike Ackermann, Vice President of Global Commercial Strategy and Alliance at Quintiles, illuminates the significant barriers to successful biopharmaceutical commercialisation.
No Comments
Pharma manufacturing supply chain
Amgen’s Madhavan Balachandran on why persistence is key to implementing an Operational Excellence campaign
No Comments
Improving workflow
Umetrics' Petter Mörée discusses the importance of process analytical technologies.
No Comments
Material management
Ubichem's Jozsef Repasi explains the importance of chemistry services in drug development.
1 of 10
Previous |
Next
Source: www.ngpharma.eu.com© 2010 GDS Publishing Ltd. All rights reserved.